These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 28252640

  • 1. Crystal structure of the BoNT/A2 receptor-binding domain in complex with the luminal domain of its neuronal receptor SV2C.
    Benoit RM, Schärer MA, Wieser MM, Li X, Frey D, Kammerer RA.
    Sci Rep; 2017 Mar 02; 7():43588. PubMed ID: 28252640
    [Abstract] [Full Text] [Related]

  • 2. Crystal Structure of Botulinum Neurotoxin A2 in Complex with the Human Protein Receptor SV2C Reveals Plasticity in Receptor Binding.
    Gustafsson R, Zhang S, Masuyer G, Dong M, Stenmark P.
    Toxins (Basel); 2018 Apr 12; 10(4):. PubMed ID: 29649119
    [Abstract] [Full Text] [Related]

  • 3. Structural insights into the interaction of botulinum neurotoxin a with its neuronal receptor SV2C.
    Li X, Brunner C, Wu Y, Leka O, Schneider G, Kammerer RA.
    Toxicon; 2020 Feb 12; 175():36-43. PubMed ID: 31783045
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A.
    Benoit RM, Frey D, Hilbert M, Kevenaar JT, Wieser MM, Stirnimann CU, McMillan D, Ceska T, Lebon F, Jaussi R, Steinmetz MO, Schertler GF, Hoogenraad CC, Capitani G, Kammerer RA.
    Nature; 2014 Jan 02; 505(7481):108-11. PubMed ID: 24240280
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A.
    Yao G, Zhang S, Mahrhold S, Lam KH, Stern D, Bagramyan K, Perry K, Kalkum M, Rummel A, Dong M, Jin R.
    Nat Struct Mol Biol; 2016 Jul 02; 23(7):656-62. PubMed ID: 27294781
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding.
    Yao G, Lam KH, Weisemann J, Peng L, Krez N, Perry K, Shoemaker CB, Dong M, Rummel A, Jin R.
    Sci Rep; 2017 Aug 07; 7(1):7438. PubMed ID: 28785006
    [Abstract] [Full Text] [Related]

  • 13. Botulinum neurotoxins: new questions arising from structural biology.
    Kammerer RA, Benoit RM.
    Trends Biochem Sci; 2014 Nov 07; 39(11):517-26. PubMed ID: 25282537
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F.
    Fu Z, Chen C, Barbieri JT, Kim JJ, Baldwin MR.
    Biochemistry; 2009 Jun 23; 48(24):5631-41. PubMed ID: 19476346
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Structural Features of Clostridium botulinum Neurotoxin Subtype A2 Cell Binding Domain.
    Gregory KS, Mahadeva TB, Liu SM, Acharya KR.
    Toxins (Basel); 2022 May 19; 14(5):. PubMed ID: 35622602
    [Abstract] [Full Text] [Related]

  • 19. High resolution crystal structures of Clostridium botulinum neurotoxin A3 and A4 binding domains.
    Davies JR, Rees J, Liu SM, Acharya KR.
    J Struct Biol; 2018 May 19; 202(2):113-117. PubMed ID: 29288126
    [Abstract] [Full Text] [Related]

  • 20. Translocation domain of botulinum neurotoxin A subtype 2 potently induces entry into neuronal cells.
    Kohda T, Tsukamoto K, Torii Y, Kozaki S, Mukamoto M.
    Microbiol Immunol; 2020 Jul 19; 64(7):502-511. PubMed ID: 32301520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.